Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2005-12-21
pubmed:abstractText
Uncontrolled hyperparathyroidism (HPT), particularly HPT resulting from chronic kidney disease (CKD), is associated with significant morbidity and cardiovascular mortality. Traditional medical therapy (eg, vitamin D sterols, calcium, phosphate binders) has been inadequate for the management of HPT and its vascular and skeletal complications.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0149-2918
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1725-51
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16368445-Animals, pubmed-meshheading:16368445-Area Under Curve, pubmed-meshheading:16368445-Calcium, pubmed-meshheading:16368445-Clinical Trials, Phase II as Topic, pubmed-meshheading:16368445-Clinical Trials, Phase III as Topic, pubmed-meshheading:16368445-Drug Interactions, pubmed-meshheading:16368445-Half-Life, pubmed-meshheading:16368445-Humans, pubmed-meshheading:16368445-Hyperparathyroidism, Primary, pubmed-meshheading:16368445-Hyperparathyroidism, Secondary, pubmed-meshheading:16368445-Kidney Failure, Chronic, pubmed-meshheading:16368445-Kidney Transplantation, pubmed-meshheading:16368445-Naphthalenes, pubmed-meshheading:16368445-Parathyroid Hormone, pubmed-meshheading:16368445-Parathyroid Neoplasms, pubmed-meshheading:16368445-Phosphorus, pubmed-meshheading:16368445-Randomized Controlled Trials as Topic, pubmed-meshheading:16368445-Renal Dialysis
pubmed:year
2005
pubmed:articleTitle
Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
pubmed:affiliation
School of Pharmacy, University of California-San Francisco, 521 Parnassus Avenue C-152, San Francisco, CA 94143-0622, USA. dongb@pharmacy.ucsf.edu
pubmed:publicationType
Journal Article, Review